Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2009
09/24/2009WO2002079384A9 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/24/2009US20090241216 Proteins Involved in After-Cooking Darkening in Potatoes
09/24/2009US20090241205 Collapsin Response Mediator Protein, CRMP; lacosamide a new analgesic and antiepileptic agent, interacts with CRMP; drug screening, pharmacogenetics
09/24/2009US20090241204 Animal model comprising in its genome a homozygous disruption of an endogenous mouse multidrug-resistance-1 (MDR-1) gene ; drug screening; pharmacokinetics and pharmacodynamics; predicting likely behaviour of a drug in mouse
09/24/2009US20090240446 Flow Assurance Monitoring
09/24/2009US20090240440 Non-Invasive Glucose Monitoring
09/24/2009US20090240439 Predicting responses to drugs or drug cadidates
09/24/2009US20090240166 Analyte sensors and methods of use
09/24/2009US20090240130 Examination Device for Blood Detection
09/24/2009US20090240129 Apparatus and method for monitoring blood glucose levels including convenient diplay of blood glucose value average and constituent values
09/24/2009US20090240038 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
09/24/2009US20090240032 Novel sugar-immobilized metal nanoparticle, method for measuring sugar-protein interaction using the same and method for recovering protein from sugar-protein interactant
09/24/2009US20090240030 Biomolecular coupling methods using 1,3-dipolar cycloaddition chemistry
09/24/2009US20090239936 Prophylactic and Therapeutic Agent for Cancer
09/24/2009US20090239916 Novel drug discovery target and medicine acting on the same
09/24/2009US20090239908 Methods of treating psychosis and schizophrenia based on polymorphisms in the cntf gene
09/24/2009US20090239888 Methods for Inhibiting Amyloid Precursor Protein and Beta-Amyloid Production and Accumulation
09/24/2009US20090239884 Methods of Treating Inflammation
09/24/2009US20090239841 Diaryl Ureas as CB1 Antagonists
09/24/2009US20090239819 Peritoneal dialysis solution test method
09/24/2009US20090239807 Methods and kits for diagnosing and/or assessing severity and treating gaucher disease
09/24/2009US20090239794 Hcv f protein and uses thereof
09/24/2009US20090239793 Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover
09/24/2009US20090239769 Expression Miniarrays and Uses Thereof
09/24/2009US20090239765 Genes whose expression is increased in response to stimulation by corticotropin-releasing hormone
09/24/2009US20090239762 Aptamers that bind abnormal cells
09/24/2009US20090239759 Multiplexed molecular analysis systems
09/24/2009US20090239755 Identification of Compounds Modifying A Cellular Response
09/24/2009US20090239312 Chromosome 6 and 9 Genes Involved in Premature Canities
09/24/2009US20090239311 Method of Differentially Diagnosing Dementias
09/24/2009US20090239310 Kokumi-imparting agent
09/24/2009US20090239309 Method of stabilizing pulmonary surfactant protein
09/24/2009US20090239308 Method and apparatus for determining copy number variation using digital pcr
09/24/2009US20090239290 Single-tube, ready-to-use assay kits, and methods using same
09/24/2009US20090239281 Moving A Small Object in A Direction
09/24/2009US20090239253 Methods of using quantitative lipid metabolome data
09/24/2009US20090239251 Method for Detecting Nanoparticles and the Use Thereof
09/24/2009US20090239247 MN and Hypoxia
09/24/2009US20090239246 Biomarkers
09/24/2009US20090239245 Method for diagnosis and prognosis of epithelial cancers
09/24/2009US20090239244 Modulators of protein phosphatase 2a and pp2a methyl esterase
09/24/2009US20090239243 Method of identifying compounds useful to treat neuronal degenerative diseases
09/24/2009US20090239242 Method for the early identification and prediction of kidney injury
09/24/2009US20090239241 Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
09/24/2009US20090239240 Mutant Forms of Fas Ligand and Uses Thereof
09/24/2009US20090239239 Eukaryotic amadoriase having excellent thermal stability, gene and recombinant dna for the eukaryotic amadoriase, and process for production of eukaryotic amadoriase having excellent thermal stability
09/24/2009US20090239238 Methods for measuring pro-inflammatory substance levels in dialysis solutions and dialysis components
09/24/2009US20090239237 METHOD FOR THE IDENTIFICATION OF A RISK FOR A THROMBOGENIC DISORDER BY DETERMINING THE TAFl-lle347 POLYMORPHISM
09/24/2009US20090239235 Facs- and Reporter Protein-Based System for High Throughput Development of Therapeutic Proteins
09/24/2009US20090239233 Single-tube, ready-to-use assay kits, and methods using same
09/24/2009US20090239229 DNA Repair Proteins Associated With Triple Negative Breast Cancers and Methods of Use Thereof
09/24/2009US20090239227 Method of diagnosing risk of myocardial infarction
09/24/2009US20090239221 diagnostic markers and clinical targets for prostate cancer; androgen regulated genes and ETS family member genes
09/24/2009US20090239220 Dlc-1 gene deleted in cancers
09/24/2009US20090239217 Stem-like cells in bone sarcomas
09/24/2009US20090239216 Novel Tannase Gene And Protein Thereof
09/24/2009US20090239215 Clonable Tag for Purification and Electron Microscopy Labeling
09/24/2009US20090239211 Method For Enrichment Involving Elimination By Mismatch Hybridisation
09/24/2009US20090239210 Proteins recruited by virus during infection of plants and method for their isolation and identification
09/24/2009US20090238929 Coffee roaster method and control
09/24/2009US20090238928 Method Of Controlling A Process In Which The Particle Size Of A Material Is Reduced, A Machine For Reducing The Particle Size Of A Material And A Method Of Calibrating Such A Machine
09/24/2009US20090238927 Method of processing avocados
09/24/2009US20090238836 Hip kinase for fertility control
09/24/2009US20090238834 Identification of protein associated with hepatocellular carcinoma, glioblastoma and lung cancer
09/24/2009US20090238833 Protein
09/24/2009US20090238832 Novel compositions and method for the treatment of psoriasis
09/24/2009US20090238831 Monoclonal antibodies and uses thereof
09/24/2009US20090238830 Protein
09/24/2009US20090238829 Stabilized single domain antibodies
09/24/2009US20090238819 Therapeutic and diagnostic agents
09/24/2009US20090238817 Anti-cell proliferative compounds and methods of use
09/24/2009US20090238812 Method for the early indentification and prediction of an abrupt reduction in kidney function in a patient undergoing cardiothoracic surgery
09/24/2009US20090238808 Process for the identification of novel enzyme interacting compounds
09/24/2009US20090238799 Conditionally-Immortalised Pancreatic Cells
09/24/2009US20090238798 Nucleotide Sequences Encoding Insecticidal Proteins
09/24/2009US20090238793 Toll like receptor (tlr) stimulation for ocular angiogenesis and macular degeneration
09/24/2009US20090238760 Antispermatogenic, spermicidal and/or antifungal composition and methods of using the same
09/24/2009US20090238755 Use of antibodies or binding portions thereof, probes, ligands, or other biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen
09/24/2009US20090238726 Quantification of analytes using internal standards
09/24/2009US20090238724 Disc for analyzing sample
09/24/2009US20090237078 Methods of evaluating peptide mixtures
09/24/2009US20090236527 Device for Indicating Illicit Substances in the Exhalation Air of a Machine Operator
09/24/2009US20090235746 Detecting And Measuring Live Pathogens Utilizing A Mass Detection Device
09/24/2009US20090235721 Reduced graphene oxide film
09/24/2009US20090235720 Dome Gas Sensor
09/24/2009DE112007002956T5 Biochipleser Biochip reader
09/24/2009DE112007002921T5 Vorrichtung und Verfahren zur Cholesterinbestimmung Apparatus and method for cholesterol determination
09/24/2009DE102009021678A1 Verfahren zum Nachweis von Omega-3-Fettsäuren im Blut A method for the detection of Omega-3 fatty acids in the blood
09/24/2009DE102008014883A1 Cell's bioactive protein production determining method, involves bonding catch antibody to beads, and analyzing spatial catch-antibody/protein/detection antibody-structures of beads for evaluating protein in flow cytometer
09/24/2009DE102008014298A1 Hochgeordnete Nanostruktur und Sensor und deren Verwendung Highly ordered nanostructure and sensor and their use
09/24/2009DE102008009185A1 Einrichtung und Verfahren zum Nachweis von Flüssigkeiten oder Substanzen aus Flüssigkeiten sowie Verwendung der Einrichtung Apparatus and method for the detection of fluids or substances from liquids as well as use of the device
09/24/2009DE102008009184A1 Vorrichtung und Verfahren mit einem Sensor-Array und mit einem Stempel sowie deren Verwendung Apparatus and method using a sensor array and having a punch, as well as their use
09/24/2009DE102005052384B4 Verfahren zur Erkennung, Markierung und Behandlung von epithelialen Lungentumorzellen sowie Mittel zur Durchführung des Verfahrens Method for detecting, marking and treating epithelial lung tumor cells as well as means for performing the method
09/24/2009DE102005019195B4 Chemische Reaktionspatrone Chemical reaction cartridge
09/24/2009CA2719020A1 Method and apparatus for analyzing individual cells or particulates using fluorescent quenching and/or bleaching
09/24/2009CA2719012A1 Method and apparatus for detecting and counting platelets individually and in aggregate clumps
09/24/2009CA2719001A1 Diagnostic of pre-symptomatic metabolic syndrome
09/24/2009CA2718995A1 Method and apparatus for determining red blood cell indices of a blood sample utilizing the intrinsic pigmentation of hemoglobin contained within the red blood cells
09/24/2009CA2718992A1 Method and apparatus for determining the hematocrit of a blood sample utilizing the intrinsic pigmentation of hemoglobin contained within the red blood cells
09/24/2009CA2718955A1 Methods and kits for the differential diagnosis of alzheimer's disease versus frontotemporal dementia, and for the diagnosis of frontotemporal dementia, comprising fas-l and ckl 18 as biomarkers